Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Revenue: 2012-2025

Historic Revenue for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $104.3 million.

  • CorMedix's Revenue rose 810.22% to $104.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.3 million, marking a year-over-year increase of 1775.48%. This contributed to the annual value of $43.5 million for FY2024, which is 126855.80% up from last year.
  • Per CorMedix's latest filing, its Revenue stood at $104.3 million for Q3 2025, which was up 162.41% from $39.7 million recorded in Q2 2025.
  • CorMedix's 5-year Revenue high stood at $104.3 million for Q3 2025, and its period low was -$13,113 during Q3 2023.
  • Moreover, its 3-year median value for Revenue was $5.7 million (2023), whereas its average is $22.6 million.
  • Per our database at Business Quant, CorMedix's Revenue slumped by 292.36% in 2023 and then soared by 606,213.33% in 2025.
  • Over the past 5 years, CorMedix's Revenue (Quarterly) stood at $56,397 in 2021, then slumped by 47.33% to $29,702 in 2022, then plummeted by 292.36% to -$13,113 in 2023, then spiked by 87,464.56% to $31.2 million in 2024, then surged by 810.22% to $104.3 million in 2025.
  • Its Revenue was $104.3 million in Q3 2025, compared to $39.7 million in Q2 2025 and $39.1 million in Q1 2025.